Join
Live feed
·
INSIDERFilingvia Quantisnow
Lineage Cell Therapeutics Inc. logo

President and CEO Culley Brian M converted options into 31,249 shares and covered exercise/tax liability with 12,547 shares, increasing direct ownership by 10% to 213,544 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
LCTX· Lineage Cell Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LCTX (Lineage Cell Therapeutics Inc.) and more on Quantisnow.